Back to NVIDIA CORP NVIDIA CORP

RXRXRXRX
9 quarters

Position history for NVIDIA CORPNVIDIA CORP's holdings in RECURSION PHARMACEUTICALS IN

No. NVIDIA exited its RXRX (Recursion Pharmaceuticals in) position in Q4 2025. Its Q3 2025 13F listed 7,706,363 shares worth $37.6M. NVIDIA already held RXRX in its Q4 2023 13F, the earliest on record, and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$76M

Total Shares Change

-7.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$4.11
0
2025-Q3
Unchanged
7.7M
0.0%
$37.6M1.0%$4.91
0
2025-Q2
Unchanged
7.7M
0.0%
$39M0.9%$5.03
0
2025-Q1
Unchanged
7.7M
0.0%
$40.8M3.6%$5.81
0
2024-Q4
Unchanged
7.7M
0.0%
$52.1M17.1%$6.77
0
2024-Q3
Unchanged
7.7M
0.0%
$50.8M11.7%$6.98
0
2024-Q2
Unchanged
7.7M
0.0%
$57.8M14.7%$7.50
0
2024-Q1
Unchanged
7.7M
0.0%
$76.8M23.1%$9.97
0
2023-Q4
First report
7.7M
-
$76M33.0%$9.86
0

Other major holders of RXRX: BAILLIE GIFFORD & CO, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used